nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CACNA1D—sinoatrial node—dilated cardiomyopathy	0.0965	0.812	CbGeAlD
Lercanidipine—CACNG1—Arrhythmogenic Right Ventricular Cardiomyopathy—SGCD—dilated cardiomyopathy	0.0502	0.141	CbGpPWpGaD
Lercanidipine—CACNG1—Arrhythmogenic Right Ventricular Cardiomyopathy—DSG2—dilated cardiomyopathy	0.0264	0.0739	CbGpPWpGaD
Lercanidipine—CACNG1—Arrhythmogenic Right Ventricular Cardiomyopathy—DES—dilated cardiomyopathy	0.02	0.056	CbGpPWpGaD
Lercanidipine—CACNG1—Arrhythmogenic Right Ventricular Cardiomyopathy—EMD—dilated cardiomyopathy	0.0186	0.052	CbGpPWpGaD
Lercanidipine—CACNG1—Arrhythmogenic Right Ventricular Cardiomyopathy—RYR2—dilated cardiomyopathy	0.0175	0.0489	CbGpPWpGaD
Lercanidipine—Pemphigus—Lisinopril—dilated cardiomyopathy	0.0171	0.034	CcSEcCtD
Lercanidipine—CACNG1—Arrhythmogenic Right Ventricular Cardiomyopathy—DSP—dilated cardiomyopathy	0.0158	0.0442	CbGpPWpGaD
Lercanidipine—CACNG1—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTN2—dilated cardiomyopathy	0.0151	0.0424	CbGpPWpGaD
Lercanidipine—Antinuclear antibody positive—Lisinopril—dilated cardiomyopathy	0.0144	0.0288	CcSEcCtD
Lercanidipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—SGCD—dilated cardiomyopathy	0.0133	0.0373	CbGpPWpGaD
Lercanidipine—CACNG1—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—dilated cardiomyopathy	0.0132	0.0371	CbGpPWpGaD
Lercanidipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—SGCD—dilated cardiomyopathy	0.0117	0.0328	CbGpPWpGaD
Lercanidipine—Felodipine—TNNC1—dilated cardiomyopathy	0.0108	0.481	CrCbGaD
Lercanidipine—Diabetic—Lisinopril—dilated cardiomyopathy	0.00981	0.0196	CcSEcCtD
Lercanidipine—CACNG1—Arrhythmogenic Right Ventricular Cardiomyopathy—LMNA—dilated cardiomyopathy	0.00907	0.0254	CbGpPWpGaD
Lercanidipine—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00822	0.0164	CcSEcCtD
Lercanidipine—CACNA1C—cardiac ventricle—dilated cardiomyopathy	0.00791	0.0665	CbGeAlD
Lercanidipine—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.00788	0.0157	CcSEcCtD
Lercanidipine—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.00737	0.0147	CcSEcCtD
Lercanidipine—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00718	0.0143	CcSEcCtD
Lercanidipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—DSG2—dilated cardiomyopathy	0.00701	0.0196	CbGpPWpGaD
Lercanidipine—Lung infiltration—Lisinopril—dilated cardiomyopathy	0.00698	0.0139	CcSEcCtD
Lercanidipine—CACNG1—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—dilated cardiomyopathy	0.00682	0.0191	CbGpPWpGaD
Lercanidipine—Blood triglycerides increased—Furosemide—dilated cardiomyopathy	0.00666	0.0133	CcSEcCtD
Lercanidipine—Nimodipine—NR3C2—dilated cardiomyopathy	0.00659	0.293	CrCbGaD
Lercanidipine—CACNG1—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGB1—dilated cardiomyopathy	0.00647	0.0181	CbGpPWpGaD
Lercanidipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—DSG2—dilated cardiomyopathy	0.00616	0.0172	CbGpPWpGaD
Lercanidipine—Cholestasis—Furosemide—dilated cardiomyopathy	0.00575	0.0115	CcSEcCtD
Lercanidipine—Serum creatinine increased—Lisinopril—dilated cardiomyopathy	0.00532	0.0106	CcSEcCtD
Lercanidipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—DES—dilated cardiomyopathy	0.00531	0.0149	CbGpPWpGaD
Lercanidipine—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00524	0.0105	CcSEcCtD
Lercanidipine—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00524	0.0105	CcSEcCtD
Lercanidipine—CACNA1C—heart—dilated cardiomyopathy	0.00519	0.0437	CbGeAlD
Lercanidipine—Felodipine—NR3C2—dilated cardiomyopathy	0.00508	0.226	CrCbGaD
Lercanidipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—EMD—dilated cardiomyopathy	0.00494	0.0138	CbGpPWpGaD
Lercanidipine—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.00485	0.00967	CcSEcCtD
Lercanidipine—CACNA1D—cardiac atrium—dilated cardiomyopathy	0.00481	0.0405	CbGeAlD
Lercanidipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—DES—dilated cardiomyopathy	0.00466	0.0131	CbGpPWpGaD
Lercanidipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—RYR2—dilated cardiomyopathy	0.00464	0.013	CbGpPWpGaD
Lercanidipine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00463	0.00924	CcSEcCtD
Lercanidipine—Throat sore—Lisinopril—dilated cardiomyopathy	0.00454	0.00906	CcSEcCtD
Lercanidipine—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.0045	0.00898	CcSEcCtD
Lercanidipine—Vasculitis—Furosemide—dilated cardiomyopathy	0.00447	0.00891	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00445	0.00887	CcSEcCtD
Lercanidipine—CACNA1C—cardiac atrium—dilated cardiomyopathy	0.00444	0.0374	CbGeAlD
Lercanidipine—Renal failure—Spironolactone—dilated cardiomyopathy	0.00441	0.00879	CcSEcCtD
Lercanidipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—EMD—dilated cardiomyopathy	0.00434	0.0121	CbGpPWpGaD
Lercanidipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—DSP—dilated cardiomyopathy	0.0042	0.0118	CbGpPWpGaD
Lercanidipine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00419	0.00835	CcSEcCtD
Lercanidipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—RYR2—dilated cardiomyopathy	0.00408	0.0114	CbGpPWpGaD
Lercanidipine—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.00404	0.00806	CcSEcCtD
Lercanidipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTN2—dilated cardiomyopathy	0.00402	0.0113	CbGpPWpGaD
Lercanidipine—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00401	0.00799	CcSEcCtD
Lercanidipine—Urine output increased—Furosemide—dilated cardiomyopathy	0.00395	0.00787	CcSEcCtD
Lercanidipine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00381	0.00759	CcSEcCtD
Lercanidipine—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00373	0.00743	CcSEcCtD
Lercanidipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—DSP—dilated cardiomyopathy	0.00369	0.0103	CbGpPWpGaD
Lercanidipine—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00367	0.00733	CcSEcCtD
Lercanidipine—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00364	0.00726	CcSEcCtD
Lercanidipine—Polyuria—Furosemide—dilated cardiomyopathy	0.00361	0.00719	CcSEcCtD
Lercanidipine—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00361	0.00719	CcSEcCtD
Lercanidipine—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.0036	0.00718	CcSEcCtD
Lercanidipine—Alopecia—Spironolactone—dilated cardiomyopathy	0.00356	0.0071	CcSEcCtD
Lercanidipine—Oliguria—Lisinopril—dilated cardiomyopathy	0.00355	0.00708	CcSEcCtD
Lercanidipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTN2—dilated cardiomyopathy	0.00354	0.0099	CbGpPWpGaD
Lercanidipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—dilated cardiomyopathy	0.00352	0.00985	CbGpPWpGaD
Lercanidipine—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00348	0.00695	CcSEcCtD
Lercanidipine—CACNA1D—Alzheimers Disease—PSEN1—dilated cardiomyopathy	0.00339	0.00948	CbGpPWpGaD
Lercanidipine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00337	0.00672	CcSEcCtD
Lercanidipine—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00336	0.00669	CcSEcCtD
Lercanidipine—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00335	0.00669	CcSEcCtD
Lercanidipine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00325	0.00649	CcSEcCtD
Lercanidipine—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00322	0.00641	CcSEcCtD
Lercanidipine—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00318	0.00634	CcSEcCtD
Lercanidipine—Malaise—Spironolactone—dilated cardiomyopathy	0.00316	0.0063	CcSEcCtD
Lercanidipine—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00309	0.00616	CcSEcCtD
Lercanidipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—dilated cardiomyopathy	0.00309	0.00865	CbGpPWpGaD
Lercanidipine—CACNA1C—Alzheimers Disease—PSEN1—dilated cardiomyopathy	0.00298	0.00833	CbGpPWpGaD
Lercanidipine—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00297	0.00592	CcSEcCtD
Lercanidipine—Discomfort—Spironolactone—dilated cardiomyopathy	0.00295	0.00588	CcSEcCtD
Lercanidipine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00289	0.00577	CcSEcCtD
Lercanidipine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00289	0.00575	CcSEcCtD
Lercanidipine—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00285	0.00569	CcSEcCtD
Lercanidipine—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00285	0.00569	CcSEcCtD
Lercanidipine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.0028	0.00559	CcSEcCtD
Lercanidipine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00279	0.00557	CcSEcCtD
Lercanidipine—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00275	0.00547	CcSEcCtD
Lercanidipine—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00273	0.00545	CcSEcCtD
Lercanidipine—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00271	0.0054	CcSEcCtD
Lercanidipine—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00268	0.00535	CcSEcCtD
Lercanidipine—CACNA1D—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00265	0.00742	CbGpPWpGaD
Lercanidipine—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00264	0.00527	CcSEcCtD
Lercanidipine—CACNA1D—Alzheimers Disease—PSEN2—dilated cardiomyopathy	0.00261	0.0073	CbGpPWpGaD
Lercanidipine—CACNA1D—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00258	0.00722	CbGpPWpGaD
Lercanidipine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00254	0.00507	CcSEcCtD
Lercanidipine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00253	0.00504	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.0025	0.00498	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00247	0.00493	CcSEcCtD
Lercanidipine—Arthritis—Lisinopril—dilated cardiomyopathy	0.00245	0.00488	CcSEcCtD
Lercanidipine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00244	0.00486	CcSEcCtD
Lercanidipine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00243	0.00484	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00242	0.00482	CcSEcCtD
Lercanidipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—LMNA—dilated cardiomyopathy	0.00241	0.00675	CbGpPWpGaD
Lercanidipine—Renal failure—Furosemide—dilated cardiomyopathy	0.0024	0.00478	CcSEcCtD
Lercanidipine—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00239	0.00476	CcSEcCtD
Lercanidipine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00236	0.0047	CcSEcCtD
Lercanidipine—CACNA1C—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00233	0.00652	CbGpPWpGaD
Lercanidipine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00231	0.0046	CcSEcCtD
Lercanidipine—Face oedema—Lisinopril—dilated cardiomyopathy	0.00229	0.00457	CcSEcCtD
Lercanidipine—CACNA1C—Alzheimers Disease—PSEN2—dilated cardiomyopathy	0.00229	0.00641	CbGpPWpGaD
Lercanidipine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00228	0.00454	CcSEcCtD
Lercanidipine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00227	0.00453	CcSEcCtD
Lercanidipine—CACNA1C—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00227	0.00635	CbGpPWpGaD
Lercanidipine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00226	0.00451	CcSEcCtD
Lercanidipine—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00223	0.00444	CcSEcCtD
Lercanidipine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00217	0.00433	CcSEcCtD
Lercanidipine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00216	0.00431	CcSEcCtD
Lercanidipine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00215	0.00428	CcSEcCtD
Lercanidipine—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00215	0.00428	CcSEcCtD
Lercanidipine—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00214	0.00427	CcSEcCtD
Lercanidipine—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00214	0.00427	CcSEcCtD
Lercanidipine—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00213	0.00424	CcSEcCtD
Lercanidipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—LMNA—dilated cardiomyopathy	0.00212	0.00593	CbGpPWpGaD
Lercanidipine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00211	0.0042	CcSEcCtD
Lercanidipine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00207	0.00413	CcSEcCtD
Lercanidipine—Asthma—Lisinopril—dilated cardiomyopathy	0.00205	0.0041	CcSEcCtD
Lercanidipine—Eye disorder—Furosemide—dilated cardiomyopathy	0.00205	0.00408	CcSEcCtD
Lercanidipine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00204	0.00407	CcSEcCtD
Lercanidipine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00202	0.00404	CcSEcCtD
Lercanidipine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00202	0.00403	CcSEcCtD
Lercanidipine—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00201	0.00402	CcSEcCtD
Lercanidipine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.002	0.00399	CcSEcCtD
Lercanidipine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.002	0.00399	CcSEcCtD
Lercanidipine—CACNA1D—Axon guidance—SCN5A—dilated cardiomyopathy	0.002	0.0056	CbGpPWpGaD
Lercanidipine—Angiopathy—Furosemide—dilated cardiomyopathy	0.00199	0.00396	CcSEcCtD
Lercanidipine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00198	0.00395	CcSEcCtD
Lercanidipine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00196	0.0039	CcSEcCtD
Lercanidipine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00195	0.00389	CcSEcCtD
Lercanidipine—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00192	0.00383	CcSEcCtD
Lercanidipine—Malnutrition—Furosemide—dilated cardiomyopathy	0.00191	0.0038	CcSEcCtD
Lercanidipine—Erythema—Furosemide—dilated cardiomyopathy	0.00191	0.0038	CcSEcCtD
Lercanidipine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00189	0.00377	CcSEcCtD
Lercanidipine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00189	0.00377	CcSEcCtD
Lercanidipine—CACNA1D—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00188	0.00527	CbGpPWpGaD
Lercanidipine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00188	0.00374	CcSEcCtD
Lercanidipine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00187	0.00372	CcSEcCtD
Lercanidipine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00183	0.00366	CcSEcCtD
Lercanidipine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00182	0.00363	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00182	0.00362	CcSEcCtD
Lercanidipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—dilated cardiomyopathy	0.00181	0.00507	CbGpPWpGaD
Lercanidipine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00181	0.0036	CcSEcCtD
Lercanidipine—Rash—Spironolactone—dilated cardiomyopathy	0.0018	0.0036	CcSEcCtD
Lercanidipine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0018	0.00359	CcSEcCtD
Lercanidipine—Renal failure—Lisinopril—dilated cardiomyopathy	0.0018	0.00359	CcSEcCtD
Lercanidipine—Vision blurred—Furosemide—dilated cardiomyopathy	0.0018	0.00358	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.0018	0.00358	CcSEcCtD
Lercanidipine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.0018	0.00358	CcSEcCtD
Lercanidipine—Headache—Spironolactone—dilated cardiomyopathy	0.00179	0.00357	CcSEcCtD
Lercanidipine—Jaundice—Lisinopril—dilated cardiomyopathy	0.00179	0.00356	CcSEcCtD
Lercanidipine—Anaemia—Furosemide—dilated cardiomyopathy	0.00176	0.00351	CcSEcCtD
Lercanidipine—CACNA1C—Axon guidance—SCN5A—dilated cardiomyopathy	0.00176	0.00492	CbGpPWpGaD
Lercanidipine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00173	0.00345	CcSEcCtD
Lercanidipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGB1—dilated cardiomyopathy	0.00172	0.00481	CbGpPWpGaD
Lercanidipine—Vertigo—Furosemide—dilated cardiomyopathy	0.00171	0.00342	CcSEcCtD
Lercanidipine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00171	0.00341	CcSEcCtD
Lercanidipine—Nausea—Spironolactone—dilated cardiomyopathy	0.0017	0.00339	CcSEcCtD
Lercanidipine—CACNA1C—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00165	0.00463	CbGpPWpGaD
Lercanidipine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00165	0.00329	CcSEcCtD
Lercanidipine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00164	0.00328	CcSEcCtD
Lercanidipine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00162	0.00324	CcSEcCtD
Lercanidipine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00162	0.00323	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00161	0.00322	CcSEcCtD
Lercanidipine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00161	0.00321	CcSEcCtD
Lercanidipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—dilated cardiomyopathy	0.00159	0.00446	CbGpPWpGaD
Lercanidipine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00159	0.00317	CcSEcCtD
Lercanidipine—Confusional state—Furosemide—dilated cardiomyopathy	0.00157	0.00313	CcSEcCtD
Lercanidipine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00155	0.0031	CcSEcCtD
Lercanidipine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00153	0.00306	CcSEcCtD
Lercanidipine—Shock—Furosemide—dilated cardiomyopathy	0.00153	0.00305	CcSEcCtD
Lercanidipine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00153	0.00304	CcSEcCtD
Lercanidipine—Flushing—Lisinopril—dilated cardiomyopathy	0.00153	0.00304	CcSEcCtD
Lercanidipine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00152	0.00304	CcSEcCtD
Lercanidipine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00151	0.00301	CcSEcCtD
Lercanidipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGB1—dilated cardiomyopathy	0.00151	0.00423	CbGpPWpGaD
Lercanidipine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00151	0.003	CcSEcCtD
Lercanidipine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00149	0.00297	CcSEcCtD
Lercanidipine—Anorexia—Furosemide—dilated cardiomyopathy	0.00148	0.00296	CcSEcCtD
Lercanidipine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00148	0.00295	CcSEcCtD
Lercanidipine—Hypotension—Furosemide—dilated cardiomyopathy	0.00145	0.0029	CcSEcCtD
Lercanidipine—Alopecia—Lisinopril—dilated cardiomyopathy	0.00145	0.0029	CcSEcCtD
Lercanidipine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00144	0.00287	CcSEcCtD
Lercanidipine—Erythema—Lisinopril—dilated cardiomyopathy	0.00143	0.00285	CcSEcCtD
Lercanidipine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00143	0.00285	CcSEcCtD
Lercanidipine—CACNA1D—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00143	0.00399	CbGpPWpGaD
Lercanidipine—Tension—Lisinopril—dilated cardiomyopathy	0.0014	0.0028	CcSEcCtD
Lercanidipine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.0014	0.00279	CcSEcCtD
Lercanidipine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.0014	0.00279	CcSEcCtD
Lercanidipine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00139	0.00277	CcSEcCtD
Lercanidipine—Somnolence—Furosemide—dilated cardiomyopathy	0.00138	0.00276	CcSEcCtD
Lercanidipine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00138	0.00274	CcSEcCtD
Lercanidipine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00135	0.0027	CcSEcCtD
Lercanidipine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00135	0.00269	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00134	0.00268	CcSEcCtD
Lercanidipine—Fatigue—Furosemide—dilated cardiomyopathy	0.00134	0.00268	CcSEcCtD
Lercanidipine—CACNA1D—Alzheimers Disease—FAS—dilated cardiomyopathy	0.00134	0.00374	CbGpPWpGaD
Lercanidipine—Constipation—Furosemide—dilated cardiomyopathy	0.00133	0.00265	CcSEcCtD
Lercanidipine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00133	0.00265	CcSEcCtD
Lercanidipine—Anaemia—Lisinopril—dilated cardiomyopathy	0.00132	0.00264	CcSEcCtD
Lercanidipine—Angioedema—Lisinopril—dilated cardiomyopathy	0.00131	0.00261	CcSEcCtD
Lercanidipine—Malaise—Lisinopril—dilated cardiomyopathy	0.00129	0.00257	CcSEcCtD
Lercanidipine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00129	0.00256	CcSEcCtD
Lercanidipine—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00128	0.0036	CbGpPWpGaD
Lercanidipine—Syncope—Lisinopril—dilated cardiomyopathy	0.00128	0.00256	CcSEcCtD
Lercanidipine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00128	0.00256	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00127	0.00254	CcSEcCtD
Lercanidipine—Palpitations—Lisinopril—dilated cardiomyopathy	0.00126	0.00252	CcSEcCtD
Lercanidipine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00126	0.00251	CcSEcCtD
Lercanidipine—CACNA1D—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00125	0.00351	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00125	0.00351	CbGpPWpGaD
Lercanidipine—Cough—Lisinopril—dilated cardiomyopathy	0.00125	0.00249	CcSEcCtD
Lercanidipine—Urticaria—Furosemide—dilated cardiomyopathy	0.00124	0.00247	CcSEcCtD
Lercanidipine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00123	0.00245	CcSEcCtD
Lercanidipine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00123	0.00245	CcSEcCtD
Lercanidipine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00122	0.00243	CcSEcCtD
Lercanidipine—Myalgia—Lisinopril—dilated cardiomyopathy	0.00122	0.00243	CcSEcCtD
Lercanidipine—Chest pain—Lisinopril—dilated cardiomyopathy	0.00122	0.00243	CcSEcCtD
Lercanidipine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00121	0.00242	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00121	0.00241	CcSEcCtD
Lercanidipine—Discomfort—Lisinopril—dilated cardiomyopathy	0.0012	0.0024	CcSEcCtD
Lercanidipine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00119	0.00238	CcSEcCtD
Lercanidipine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00118	0.00235	CcSEcCtD
Lercanidipine—CACNA1C—Alzheimers Disease—FAS—dilated cardiomyopathy	0.00117	0.00329	CbGpPWpGaD
Lercanidipine—Shock—Lisinopril—dilated cardiomyopathy	0.00115	0.00229	CcSEcCtD
Lercanidipine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00115	0.00229	CcSEcCtD
Lercanidipine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00114	0.00228	CcSEcCtD
Lercanidipine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00114	0.00227	CcSEcCtD
Lercanidipine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00113	0.00226	CcSEcCtD
Lercanidipine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00113	0.00225	CcSEcCtD
Lercanidipine—Asthenia—Furosemide—dilated cardiomyopathy	0.00112	0.00223	CcSEcCtD
Lercanidipine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00111	0.00222	CcSEcCtD
Lercanidipine—CACNA1C—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.0011	0.00309	CbGpPWpGaD
Lercanidipine—Pruritus—Furosemide—dilated cardiomyopathy	0.0011	0.0022	CcSEcCtD
Lercanidipine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00109	0.00218	CcSEcCtD
Lercanidipine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00107	0.00212	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00106	0.00212	CcSEcCtD
Lercanidipine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00106	0.00211	CcSEcCtD
Lercanidipine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00105	0.00209	CcSEcCtD
Lercanidipine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00104	0.00208	CcSEcCtD
Lercanidipine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00104	0.00207	CcSEcCtD
Lercanidipine—CACNA1D—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00103	0.0029	CbGpPWpGaD
Lercanidipine—Dizziness—Furosemide—dilated cardiomyopathy	0.00103	0.00205	CcSEcCtD
Lercanidipine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00103	0.00205	CcSEcCtD
Lercanidipine—CACNA1D—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00102	0.00285	CbGpPWpGaD
Lercanidipine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00102	0.00202	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00101	0.00201	CcSEcCtD
Lercanidipine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00101	0.00201	CcSEcCtD
Lercanidipine—Constipation—Lisinopril—dilated cardiomyopathy	0.000999	0.00199	CcSEcCtD
Lercanidipine—Vomiting—Furosemide—dilated cardiomyopathy	0.00099	0.00197	CcSEcCtD
Lercanidipine—Rash—Furosemide—dilated cardiomyopathy	0.000982	0.00196	CcSEcCtD
Lercanidipine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000981	0.00196	CcSEcCtD
Lercanidipine—CACNA1D—NCAM signaling for neurite out-growth—RAF1—dilated cardiomyopathy	0.000979	0.00274	CbGpPWpGaD
Lercanidipine—Headache—Furosemide—dilated cardiomyopathy	0.000975	0.00194	CcSEcCtD
Lercanidipine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000963	0.00192	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000955	0.0019	CcSEcCtD
Lercanidipine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000928	0.00185	CcSEcCtD
Lercanidipine—Nausea—Furosemide—dilated cardiomyopathy	0.000925	0.00184	CcSEcCtD
Lercanidipine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000923	0.00184	CcSEcCtD
Lercanidipine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000923	0.00184	CcSEcCtD
Lercanidipine—CACNA1C—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000909	0.00255	CbGpPWpGaD
Lercanidipine—CACNA1C—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000893	0.0025	CbGpPWpGaD
Lercanidipine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000861	0.00172	CcSEcCtD
Lercanidipine—CACNA1C—NCAM signaling for neurite out-growth—RAF1—dilated cardiomyopathy	0.000861	0.00241	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—PSEN2—dilated cardiomyopathy	0.000842	0.00236	CbGpPWpGaD
Lercanidipine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000838	0.00167	CcSEcCtD
Lercanidipine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000826	0.00165	CcSEcCtD
Lercanidipine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000799	0.00159	CcSEcCtD
Lercanidipine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000772	0.00154	CcSEcCtD
Lercanidipine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000743	0.00148	CcSEcCtD
Lercanidipine—CACNA1C—Axon guidance—PSEN2—dilated cardiomyopathy	0.00074	0.00207	CbGpPWpGaD
Lercanidipine—Rash—Lisinopril—dilated cardiomyopathy	0.000737	0.00147	CcSEcCtD
Lercanidipine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000736	0.00147	CcSEcCtD
Lercanidipine—Headache—Lisinopril—dilated cardiomyopathy	0.000732	0.00146	CcSEcCtD
Lercanidipine—Nausea—Lisinopril—dilated cardiomyopathy	0.000694	0.00138	CcSEcCtD
Lercanidipine—CACNA1D—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000601	0.00168	CbGpPWpGaD
Lercanidipine—CACNA1D—Alzheimers Disease—TNF—dilated cardiomyopathy	0.000567	0.00159	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ANKRD1—dilated cardiomyopathy	0.000567	0.00159	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—TAZ—dilated cardiomyopathy	0.000533	0.00149	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000528	0.00148	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—ITGB1—dilated cardiomyopathy	0.000527	0.00148	CbGpPWpGaD
Lercanidipine—CACNA1C—Alzheimers Disease—TNF—dilated cardiomyopathy	0.000499	0.0014	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ANKRD1—dilated cardiomyopathy	0.000498	0.0014	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—SDHA—dilated cardiomyopathy	0.000482	0.00135	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—TAZ—dilated cardiomyopathy	0.000469	0.00131	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—ITGB1—dilated cardiomyopathy	0.000463	0.0013	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—SDHA—dilated cardiomyopathy	0.000424	0.00119	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—RAC1—dilated cardiomyopathy	0.000424	0.00119	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000376	0.00105	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—RAC1—dilated cardiomyopathy	0.000372	0.00104	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—ITGB1—dilated cardiomyopathy	0.00033	0.000926	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—CD36—dilated cardiomyopathy	0.000321	0.000898	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	0.000305	0.000855	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—RAC1—dilated cardiomyopathy	0.000302	0.000847	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	0.000287	0.000804	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—CD36—dilated cardiomyopathy	0.000282	0.000789	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—RAF1—dilated cardiomyopathy	0.000281	0.000787	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—RAC1—dilated cardiomyopathy	0.000266	0.000744	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	0.000259	0.000727	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—RAF1—dilated cardiomyopathy	0.000247	0.000691	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	0.000221	0.000618	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	0.000207	0.000581	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—RAF1—dilated cardiomyopathy	0.0002	0.000561	CbGpPWpGaD
Lercanidipine—CACNA1D—Axon guidance—EGFR—dilated cardiomyopathy	0.000193	0.00054	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	0.000188	0.000525	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—RAF1—dilated cardiomyopathy	0.000176	0.000493	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—EGFR—dilated cardiomyopathy	0.000169	0.000474	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000157	0.000439	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	0.000147	0.000413	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—EGFR—dilated cardiomyopathy	0.000137	0.000385	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	0.000133	0.000374	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GPX1—dilated cardiomyopathy	0.000131	0.000367	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—TNF—dilated cardiomyopathy	0.000131	0.000367	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CD36—dilated cardiomyopathy	0.000128	0.000357	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—EGFR—dilated cardiomyopathy	0.000121	0.000338	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GPX1—dilated cardiomyopathy	0.000115	0.000322	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—TNF—dilated cardiomyopathy	0.000115	0.000322	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—AGT—dilated cardiomyopathy	0.000115	0.000322	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CD36—dilated cardiomyopathy	0.000112	0.000314	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000103	0.000287	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—AGT—dilated cardiomyopathy	0.000101	0.000283	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	9.64e-05	0.00027	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	8.72e-05	0.000244	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	7.05e-05	0.000197	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	6.87e-05	0.000192	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	6.18e-05	0.000173	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	5.1e-05	0.000143	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	4.96e-05	0.000139	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	4.47e-05	0.000125	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	3.62e-05	0.000101	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	3.53e-05	9.88e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	3.18e-05	8.9e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.37e-05	6.63e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.31e-05	6.46e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.08e-05	5.82e-05	CbGpPWpGaD
